In a murine model of pancreatic cancer, treatment with anti-PD-L1 or anti-PD-1 mAbs enhanced the infiltration of CD8+ T cells and significantly increased the expression of IFN-γ, granzyme B and perforin in implanted tumors. The gene discussed is CD8A; the disease is pancreatic neoplasm.